◀ Back to B2M
B2M — KIR3DL1
Pathways - manually collected, often from reviews:
-
Reactome Reaction:
B2M
→
KIR3DL1
(reaction)
Vilches et al., Annu Rev Immunol 2002, Boyington et al., Mol Immunol 2002, Uhrberg et al., Eur J Immunol 2005
-
Reactome Reaction:
B2M
→
KIR3DL1
(indirect_complex)
Vilches et al., Annu Rev Immunol 2002, Boyington et al., Mol Immunol 2002, Uhrberg et al., Eur J Immunol 2005
Text-mined interactions from Literome
Al Omar et al., Immunology 2011
(Carcinoma, Non-Small-Cell Lung...) :
A similar result was obtained for
CD158e in the
presence of its ligand
HLA-Bw4 in NSCLC patients ( P = 0.003 ) ; this was entirely attributable to the Bw4I group of alleles in the presence of which a fivefold higher percentage of CD158e ( + ) NK cells was found in NSCLC patients than controls
Al Omar et al., Int Immunol 2012
(Carcinoma, Non-Small-Cell Lung...) :
CD158e levels on CD56+CD3+ cells were increased in the
presence of its ligand
HLA-Bw4 compared with controls